| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:00:55 UTC |
|---|
| Update Date | 2021-09-14 15:47:46 UTC |
|---|
| HMDB ID | HMDB0014037 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 6-Hydroxyfluvastatin |
|---|
| Description | 6-Hydroxyfluvastatin is only found in individuals that have used or taken Fluvastatin. 6-Hydroxyfluvastatin is a metabolite of Fluvastatin. 6-hydroxyfluvastatin belongs to the family of Indoles. These are compounds containing an indole moiety, which consists of pyrrole ring fused to benzene to form 2,3-benzopyrrole. |
|---|
| Structure | CC(C)N1C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C12 InChI=1S/C24H26FNO5/c1-14(2)26-21(10-8-17(27)11-19(29)13-23(30)31)24(15-3-5-16(25)6-4-15)20-9-7-18(28)12-22(20)26/h3-10,12,14,17,19,27-29H,11,13H2,1-2H3,(H,30,31)/b10-8+/t17-,19-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (3S,5R,6E)-7-[3-(4-Fluorophenyl)-6-hydroxy-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoate | Generator |
|
|---|
| Chemical Formula | C24H26FNO5 |
|---|
| Average Molecular Weight | 427.4653 |
|---|
| Monoisotopic Molecular Weight | 427.179501152 |
|---|
| IUPAC Name | (3S,5R,6E)-7-[3-(4-fluorophenyl)-6-hydroxy-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid |
|---|
| Traditional Name | (3S,5R,6E)-7-[3-(4-fluorophenyl)-6-hydroxy-1-isopropylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC(C)N1C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C12 |
|---|
| InChI Identifier | InChI=1S/C24H26FNO5/c1-14(2)26-21(10-8-17(27)11-19(29)13-23(30)31)24(15-3-5-16(25)6-4-15)20-9-7-18(28)12-22(20)26/h3-10,12,14,17,19,27-29H,11,13H2,1-2H3,(H,30,31)/b10-8+/t17-,19-/m0/s1 |
|---|
| InChI Key | WSYBZSUCJJHTIP-CLFQVBOOSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenylpyrroles. These are polycyclic aromatic compounds containing a benzene ring linked to a pyrrole ring through a CC or CN bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Pyrroles |
|---|
| Sub Class | Substituted pyrroles |
|---|
| Direct Parent | Phenylpyrroles |
|---|
| Alternative Parents | |
|---|
| Substituents | - 3-phenylpyrrole
- N-alkylindole
- Hydroxyindole
- Indole or derivatives
- Medium-chain hydroxy acid
- Indole
- Medium-chain fatty acid
- 1-hydroxy-2-unsubstituted benzenoid
- Hydroxy fatty acid
- Heterocyclic fatty acid
- Halogenated fatty acid
- Beta-hydroxy acid
- Halobenzene
- Fluorobenzene
- Unsaturated fatty acid
- Monocyclic benzene moiety
- Hydroxy acid
- Benzenoid
- Fatty acid
- Fatty acyl
- Aryl halide
- Aryl fluoride
- Heteroaromatic compound
- Secondary alcohol
- Carboxylic acid derivative
- Carboxylic acid
- Azacycle
- Monocarboxylic acid or derivatives
- Organooxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Alcohol
- Carbonyl group
- Organic oxide
- Organopnictogen compound
- Organonitrogen compound
- Organofluoride
- Organohalogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 7.14 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 12.6981 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.81 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 54.3 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2391.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 223.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 191.9 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 172.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 167.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 623.1 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 451.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 72.9 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1068.5 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 500.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1365.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 337.8 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 414.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 235.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 176.3 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 6-Hydroxyfluvastatin,1TMS,isomer #1 | CC(C)N1C(/C=C/[C@@H](C[C@H](O)CC(=O)O)O[Si](C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21 | 3513.6 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,1TMS,isomer #2 | CC(C)N1C(/C=C/[C@H](O)C[C@@H](CC(=O)O)O[Si](C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21 | 3447.3 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,1TMS,isomer #3 | CC(C)N1C(/C=C/[C@H](O)C[C@H](O)CC(=O)O[Si](C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21 | 3464.1 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,1TMS,isomer #4 | CC(C)N1C(/C=C/[C@H](O)C[C@H](O)CC(=O)O)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C)C=C21 | 3500.0 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,2TMS,isomer #1 | CC(C)N1C(/C=C/[C@@H](C[C@@H](CC(=O)O)O[Si](C)(C)C)O[Si](C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21 | 3424.9 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,2TMS,isomer #2 | CC(C)N1C(/C=C/[C@@H](C[C@H](O)CC(=O)O[Si](C)(C)C)O[Si](C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21 | 3434.8 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,2TMS,isomer #3 | CC(C)N1C(/C=C/[C@@H](C[C@H](O)CC(=O)O)O[Si](C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C)C=C21 | 3473.2 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,2TMS,isomer #4 | CC(C)N1C(/C=C/[C@H](O)C[C@@H](CC(=O)O[Si](C)(C)C)O[Si](C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21 | 3392.5 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,2TMS,isomer #5 | CC(C)N1C(/C=C/[C@H](O)C[C@@H](CC(=O)O)O[Si](C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C)C=C21 | 3430.5 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,2TMS,isomer #6 | CC(C)N1C(/C=C/[C@H](O)C[C@H](O)CC(=O)O[Si](C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C)C=C21 | 3435.0 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,3TMS,isomer #1 | CC(C)N1C(/C=C/[C@@H](C[C@@H](CC(=O)O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21 | 3411.9 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,3TMS,isomer #2 | CC(C)N1C(/C=C/[C@@H](C[C@@H](CC(=O)O)O[Si](C)(C)C)O[Si](C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C)C=C21 | 3456.5 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,3TMS,isomer #3 | CC(C)N1C(/C=C/[C@@H](C[C@H](O)CC(=O)O[Si](C)(C)C)O[Si](C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C)C=C21 | 3439.3 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,3TMS,isomer #4 | CC(C)N1C(/C=C/[C@H](O)C[C@@H](CC(=O)O[Si](C)(C)C)O[Si](C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C)C=C21 | 3405.2 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,4TMS,isomer #1 | CC(C)N1C(/C=C/[C@@H](C[C@@H](CC(=O)O[Si](C)(C)C)O[Si](C)(C)C)O[Si](C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C)C=C21 | 3429.9 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,1TBDMS,isomer #1 | CC(C)N1C(/C=C/[C@@H](C[C@H](O)CC(=O)O)O[Si](C)(C)C(C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21 | 3749.8 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,1TBDMS,isomer #2 | CC(C)N1C(/C=C/[C@H](O)C[C@@H](CC(=O)O)O[Si](C)(C)C(C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21 | 3676.6 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,1TBDMS,isomer #3 | CC(C)N1C(/C=C/[C@H](O)C[C@H](O)CC(=O)O[Si](C)(C)C(C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21 | 3696.2 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,1TBDMS,isomer #4 | CC(C)N1C(/C=C/[C@H](O)C[C@H](O)CC(=O)O)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C21 | 3722.4 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,2TBDMS,isomer #1 | CC(C)N1C(/C=C/[C@@H](C[C@@H](CC(=O)O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21 | 3849.7 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,2TBDMS,isomer #2 | CC(C)N1C(/C=C/[C@@H](C[C@H](O)CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21 | 3864.4 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,2TBDMS,isomer #3 | CC(C)N1C(/C=C/[C@@H](C[C@H](O)CC(=O)O)O[Si](C)(C)C(C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C21 | 3921.6 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,2TBDMS,isomer #4 | CC(C)N1C(/C=C/[C@H](O)C[C@@H](CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21 | 3799.3 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,2TBDMS,isomer #5 | CC(C)N1C(/C=C/[C@H](O)C[C@@H](CC(=O)O)O[Si](C)(C)C(C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C21 | 3853.6 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,2TBDMS,isomer #6 | CC(C)N1C(/C=C/[C@H](O)C[C@H](O)CC(=O)O[Si](C)(C)C(C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C21 | 3856.0 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,3TBDMS,isomer #1 | CC(C)N1C(/C=C/[C@@H](C[C@@H](CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21 | 3985.2 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,3TBDMS,isomer #2 | CC(C)N1C(/C=C/[C@@H](C[C@@H](CC(=O)O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C21 | 4052.4 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,3TBDMS,isomer #3 | CC(C)N1C(/C=C/[C@@H](C[C@H](O)CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C21 | 4053.1 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,3TBDMS,isomer #4 | CC(C)N1C(/C=C/[C@H](O)C[C@@H](CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C21 | 3991.7 | Semi standard non polar | 33892256 | | 6-Hydroxyfluvastatin,4TBDMS,isomer #1 | CC(C)N1C(/C=C/[C@@H](C[C@@H](CC(=O)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)O[Si](C)(C)C(C)(C)C)=C(C2=CC=C(F)C=C2)C2=CC=C(O[Si](C)(C)C(C)(C)C)C=C21 | 4171.9 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 6-Hydroxyfluvastatin GC-MS (Non-derivatized) - 70eV, Positive | splash10-006y-9258400000-8fd1275d9812efb4c883 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 6-Hydroxyfluvastatin GC-MS (3 TMS) - 70eV, Positive | splash10-004i-3023039000-748e1da207981c192aac | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 6-Hydroxyfluvastatin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-Hydroxyfluvastatin 10V, Positive-QTOF | splash10-03dl-0008900000-a79780c239fb3ea9bf8f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-Hydroxyfluvastatin 20V, Positive-QTOF | splash10-03xu-2019200000-2ac4db5d6457311a3f6e | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-Hydroxyfluvastatin 40V, Positive-QTOF | splash10-00kf-7196000000-b4d0b51825f97e556db0 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-Hydroxyfluvastatin 10V, Negative-QTOF | splash10-004i-1006900000-9be592465f9bec1dc2e4 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-Hydroxyfluvastatin 20V, Negative-QTOF | splash10-0c09-6109200000-51e7f084d928a364b947 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-Hydroxyfluvastatin 40V, Negative-QTOF | splash10-0a4i-9014000000-ab98d83268126f85ebc2 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-Hydroxyfluvastatin 10V, Positive-QTOF | splash10-01u0-0023900000-c7e6c42d85118972c7f0 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-Hydroxyfluvastatin 20V, Positive-QTOF | splash10-03ec-0059500000-28ea705d7588f8322ede | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-Hydroxyfluvastatin 40V, Positive-QTOF | splash10-0ued-0091000000-51d16042f82bcd0c3190 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-Hydroxyfluvastatin 10V, Negative-QTOF | splash10-004i-0004900000-635f4ca0b7765dfe5fce | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-Hydroxyfluvastatin 20V, Negative-QTOF | splash10-074r-2009000000-19e5d0655e975426fbd1 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 6-Hydroxyfluvastatin 40V, Negative-QTOF | splash10-0006-4096000000-4ce073e6cf4b2154258f | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|